Should You Buy CTI BioPharma Corp (CTIC) Stock Friday Morning?

Friday, May 13, 2022 07:03 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy CTI BioPharma Corp (CTIC) Stock Friday Morning?

CTI BioPharma Corp (CTIC) is higher by Friday morning, with the stock climbing 5.46% in pre-market trading to 3.86. CTIC's short-term technical score of 91 indicates that the stock has traded more bullishly over the last month than 91% of stocks on the market. In the Biotechnology industry, which ranks 132 out of 146 industries, CTI BioPharma Corp ranks higher than 98% of stocks. CTI BioPharma Corp has fallen 13.68% over the past month, closing at $4.34 on April 15. During this period of time, the stock fell as low as $3.55 and as high as $5.76. CTIC has an average analyst recommendation of Strong Buy. The company has an average price target of $7.55.

CTIC has an Overall Score of 89. Find out what this means to you and get the rest of the rankings on CTIC!

See Full CTIC Report

CTI BioPharma Corp has a Long-Term Technical rank of 94. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 6% of the market scoring higher. In the Biotechnology industry which is number 141 by this metric, CTIC ranks better than 99% of stocks.

Important Dates for Investors in CTIC:

-CTI BioPharma Corp is set to release earnings on 8/10/2022. Over the last 12 months, the company has reported EPS of $-1.09. -We do not have a set dividend date for CTI BioPharma Corp at this time. Click Here To Get The Full Report on CTI BioPharma Corp (CTIC)